Patents by Inventor Graham McGowan

Graham McGowan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9029607
    Abstract: A para-methoxy protected benzaldehyde useful in preparation of treprostinil, and of formula: (Formula (1)) is prepared by subjecting to Claisen re-arrangement a substituted benzaldehyde of formula (1a): (Formula (Ia)) to form the m-hydroxy-substituted benzaldehyde of formula (1b): (Formula (Ib)) and then reacting compound (1b) with a p-methoxybenzyl (PMB) compound to form a PMB-substituted benzaldehyde of formula (1).
    Type: Grant
    Filed: July 22, 2011
    Date of Patent: May 12, 2015
    Assignee: Alphora Research Inc.
    Inventors: Graham McGowan, Boris Gorin, Bruce Goodbrand, Elena Bejan
  • Publication number: 20130331593
    Abstract: Treprostinil is prepared by a process which involves Pauson-Khan cyclization of an an alkene-substituted, alkyne-substituted benzene corresponding to formula: (I) where PMB represents para-methoxy benzyl protecting group and R1 and R2 are alcohol protecting groups. Following cyclization, the resulting compound can be subjected to several chemical trans-formations followed by alkylation, hydrolysis and salt formation to yield treprostinil sodium. The use of para-methoxybenzyl group as the phenolic protecting group confers several process advantages that result in simplified purification of the final product and improved yields.
    Type: Application
    Filed: July 22, 2011
    Publication date: December 12, 2013
    Applicant: ALPHORA RESEARCH INC.
    Inventors: Graham Mcgowan, Walter Giust, Danielle Marie Di Donato, Teng-Ko Ngooi, Jan Oudenes
  • Publication number: 20130211145
    Abstract: A para-methoxy protected benzaldehyde useful in preparation of treprostinil, and of formula: (Formula (1)) is prepared by subjecting to Claisen re-arrangement a substituted benzaldehyde of formula (1a): (Formula (Ia)) to form the m-hydroxy-substituted benzaldehyde of formula (1b): (Formula (Ib)) and then reacting compound (1b) with a p-methoxybenzyl (PMB) compound to form a PMB-substituted benzaldehyde of formula (1).
    Type: Application
    Filed: July 22, 2011
    Publication date: August 15, 2013
    Applicant: ALPHORA RESEARCH INC.
    Inventors: Graham Mcgowan, Boris Gorin, Bruce Goodbrand, Elena Bejan
  • Publication number: 20130023681
    Abstract: 1 a-hydroxy vitamin D2 (doxercalciferol) of exceptionally high purity and stability is prepared by a process involving chromatographically purifying 1 ?-hydroxyvitamin D2 monoacetate, chemically removing the acetate protectant group from the purified product to form 1 ?-hydroxyvitamin D2, and precipitating the 1 a-hydroxyvitamin D2 so formed from a mixed organic solvent consisting essentially of at least one C1-C6 dialkyl ether or C1-C6 alkyl ester, and at least one C5-C12 hydrocarbon.
    Type: Application
    Filed: March 29, 2011
    Publication date: January 24, 2013
    Applicant: ALPHORA RESEARCH INC.
    Inventors: Graham McGowan, Boris Ivanovich Gorin